Thus, I believe this requirement to be a relatively minor point in industry. Industry prides itself on the skill level of those entrusted with animal care and manipulations. Centralization of facilities allows for better accountability and the unique regulations dictated by other agencies create an environment that encourages the enhancement of training skills and thorough scrutiny of same. Future of MAB Production from Industry's Perspective Bad News Industry has little to gain from being the benchtop basic scientist working on enhanced in vitro applications. Industry has a good comfort level and track record with how they conduct ascites MAB production and has developed confidence in contract service laboratories which likewise may generate MAB by ascites production.
Industry is very time conscious.
Products may have great humanitarian incentives in addition to monetary gains but regardless of the motive, market timing is critical. This being the real world case, time and resources are prioritized to product development, not project development. And perhaps most important, industry has to generally have a cautious conservative approach to new technology. Good news Industry typically moves en masse. Successes in in vitro MAB production in a company's laboratory will typically drive competitors to match the stakes thereby creating a flood of positive momentum.